tm logo
CLERAMARC
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 21 Nov 2024

Last Applicant/ Owned by

66 Hudson Boulevard East

New York

NY

10001-2192

Serial Number

98865455 filed on 21st Nov 2024

Registration Number

N/A

Correspondent Address

Heather A. McDonald

Heather A. McDonald Pfizer Inc.

New York, NY 10001-2192

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CLERAMARC

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disor Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98865455

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T447386

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
21st Nov 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21st Nov 2024NEW APPLICATION ENTERED